Abstract

H.B. Fuller will report fiscal second-quarter 2026 results on June 24, 2026, Post Market, with this preview summarizing consensus expectations for revenue, earnings, and margins, alongside key business dynamics, segment highlights, and institutional views that frame the market debate going into the print.

Market Forecast

Consensus points to a steady rebound in fiscal second-quarter performance: revenue is projected at 923.63 million US dollars, up 2.63% year over year; adjusted EPS is estimated at 1.38, up 27.68% year over year; and EBIT is forecast at 132.90 million US dollars, up 18.64% year over year. Forecast gross margin and net margin have not been formally guided; the setup implies operating leverage from pricing and mix if volumes hold in core categories.

The core business mix remains anchored by Hygiene, Health and Consumables Adhesives, where pricing actions and cost controls are expected to preserve margin resiliency even if volumes are mixed across end-markets. Engineering Adhesives stands out as the most promising near-term contributor at 242.45 million US dollars last quarter, with expected growth that should outpace the company’s projected 2.63% year-over-year revenue increase, supported by electronics and transportation demand and early aerospace investments.

Last Quarter Review

In fiscal first-quarter 2026, H.B. Fuller delivered revenue of 770.84 million US dollars, a gross profit margin of 31.34%, GAAP net profit attributable to the parent company of 21.05 million US dollars, a net profit margin of 2.73%, and adjusted EPS of 0.57, up 5.56% year over year, with total revenue down 2.26% year over year.

A notable highlight was the sharp year-over-year acceleration in GAAP net income, which rose roughly 60% as pricing discipline and cost management offset soft volumes, and the company subsequently raised its full-year adjusted EPS outlook to 4.55–4.90. The business mix was led by Hygiene, Health and Consumables Adhesives at 346.53 million US dollars (44.95% of sales), followed by Engineering Adhesives at 242.45 million US dollars and Construction Adhesives at 181.87 million US dollars, with overall revenue down 2.26% year over year and quarter-on-quarter net profit down 29.22%, underscoring seasonality and normalization after year-end.

Current Quarter Outlook

Main business: Hygiene, Health and Consumables Adhesives

This segment remains the company’s revenue anchor and near-term margin stabilizer. The announced global price increases of at least 10%, effective April 1, 2026, provide an important buffer against raw-material, energy, and logistics cost variability, and should support a sequential uplift in gross profit dollars as the quarter laps early-year cost inputs. While pricing actions can curb volumes at the margin in more price-sensitive niches, mix management and targeted customer partnerships in hygiene and medical consumables are positioned to hold share where performance and reliability are critical. Assuming stable service levels, the net effect for fiscal second-quarter is tilted toward improved dollar margins, even if unit volumes are choppy across regions.

There is also a favorable margin mix element within hygiene and health that can surface when premium chemistries and differentiated formulations are specified for high-value applications. These higher-value placements typically carry longer qualification cycles but also tend to be stickier in the installed base once adopted. In the quarter under review, the combination of pricing, disciplined cost control, and procurement leverage should keep the segment’s contribution resilient, helping to bridge any short-term volume fluctuations and maintaining the company’s consolidated gross margin trajectory around the low-30% zone achieved last quarter. Management’s comments in the prior release around global procurement and cost discipline suggest further efficiency extraction remains a tangible lever this quarter.

The demand cadence across consumer-linked consumables can vary by geography, and any mid-quarter destocking by customers would be a watch point. Even so, the company’s heightened focus on service continuity amid supply chain disruptions positions the segment to capture incremental orders where competitors struggle with availability. Taken together, that underpins a case for steady segment performance this quarter, with the pricing roll-through doing most of the heavy lifting for year-over-year expansion in profit dollars.

Most promising business: Engineering Adhesives and early aerospace momentum

Engineering Adhesives is poised to deliver above-company growth versus the projected 2.63% year-over-year increase in consolidated revenue, aided by trends across electronics assembly, transportation light-weighting, and industrial applications that favor higher-specification adhesives and sealants. The announced aerospace manufacturing center in Charlotte, North Carolina, slated for early 2027 opening, underscores a multi-year intent to scale specialty aerospace solutions; in the near term, it provides commercial signaling that can support pipeline development and customer qualification in aviation platforms. While the facility is not yet online, the ecosystem around aerospace typically begins to convert into orders through long qualification timelines, suggesting incremental momentum could begin to register in Engineering Adhesives as customers validate products for future programs.

This segment generally benefits from richer mix, technical service intensity, and application engineering that can sustain higher margins. As a result, incremental revenue in Engineering Adhesives often carries an outsized impact on consolidated profitability. In fiscal second-quarter 2026, that dynamic could be amplified by the company’s earlier price increases and procurement tailwinds if raw-material cost indices remain benign relative to late 2025 levels. The key sensitivity is timing: project-driven revenue in engineered solutions can be lumpy, and management’s ability to sequence deliveries and commissioning windows will influence quarterly earnings cadence.

Another constructive feature is geographic and end-market diversity within Engineering Adhesives, which can smooth cyclical dips in any single vertical. With electronics orders showing selective stability and transportation demand aided by content growth trends in EVs and lightweighting, the segment sets up as a positive contributor to year-over-year EBIT growth. The consensus call for company-wide EBIT up 18.64% year over year reflects, in part, the expected mix contribution from Engineering Adhesives and its improving pricing discipline.

Near-term stock drivers this quarter

The first and most visible swing factor is the throughput of the April 1 pricing actions into reported revenue and margins. If pass-throughs stick with limited volume attrition, there is a clear path for upside versus the 923.63 million US dollars consensus revenue, especially if demand holds in hygiene/medical and engineered applications. Conversely, heavy price elasticity in select categories could cap revenue upside but still support EBIT given favorable price-cost spread, which would be consistent with the consensus skew toward stronger EPS growth (+27.68% year over year) versus revenue growth (+2.63% year over year).

Second, corporate actions and governance remain in focus. The unsolicited proposal to acquire Advanced Medical Solutions carries a June 18, 2026 decision deadline under applicable rules, and a vocal shareholder has argued against the transaction and urged a strategic alternatives review. Clarity on whether the company proceeds or walks away will influence perceived risk, leverage trajectory, and valuation multiple near term. If the company opts for discipline—either on price or structure—the market could refocus on the fundamental earnings cadence and the raised full-year adjusted EPS range of 4.55–4.90, which already indicates confidence in cost control and pricing power. If it pursues the transaction, investors will weigh potential synergies against integration and balance-sheet risk.

Third, operating execution on cash and costs will matter for equity sentiment. The prior quarter’s 31.34% gross margin and 2.73% net profit margin set a baseline; sustaining gross margin near 31% while accelerating revenue could deliver the forecast 18.64% EBIT growth, if SG&A discipline persists. Working-capital management and inventory turns will be important following price actions, as will any incremental FX headwind in Europe or Latin America. The dividend increase to 0.245 per share payable in May signals confidence in cash generation, and an in-line or better free-cash-flow trajectory in fiscal second-quarter would reinforce that message.

Analyst Opinions

Bullish views outnumber bearish commentaries by roughly 2:1 over the past six months, and the consensus stance skews positive heading into fiscal second-quarter results. A notable example is Deutsche Bank maintaining a Buy rating while trimming its price target to 70.00 US dollars, indicating continued confidence in the earnings recovery path despite macro variability. In parallel, the company’s average rating is cited as overweight with a mean price target of about 70.43 US dollars, implying an expectation for further progress on margins and cash flow as pricing and procurement levers play through the P&L.

The bull case emphasizes the setup embedded in consensus: adjusted EPS growth projected at 27.68% year over year on only 2.63% revenue growth, reflecting improved price-cost spread, procurement efficiencies, and richer mix from Engineering Adhesives and specialty construction applications. Supportive corporate actions—such as the dividend increase in April—reinforce the view that management is confident in cash generation while continuing to invest behind higher-return platforms, including aerospace. On top of that, an upgrade from a major broker to Neutral from Underweight earlier this quarter removes a source of downside debate and narrows the distribution of outcomes many investors were bracing for at the start of the year.

Bulls also point to the company’s raised full-year adjusted EPS guidance of 4.55–4.90 as a strong signal that cost control, pricing, and mix can offset uneven volumes in some markets. The expected quarter-over-quarter step-up from the seasonally soft first quarter, coupled with price increases that began on April 1, provides identifiable catalysts for sequential margin expansion in fiscal second-quarter. If reported results confirm the consensus trajectory for EBIT up 18.64% year over year, bulls argue that multiple support improves and that the shares can re-rate toward the upper-60s given a mean target around 70.00–70.43 US dollars.

In sum, the majority institutional view is constructive: maintain focus on the earnings algorithm—price, cost, and mix—while monitoring corporate decisions around the proposed acquisition and the pace of aerospace and engineered solutions initiatives. A print that aligns with the forecasted revenue of 923.63 million US dollars and delivers on the implied operating leverage should keep the positive stance intact and help validate the stronger full-year outlook signaled in late March.